FDA
approval
· 2023-08-18
FDA Approved: CITALOPRAM — Supplemental Application (Chartwell Governmental & Specialty RX, LLC.)
Summary
FDA approved a supplemental application for the generic antidepressant citalopram submitted by Chartwell Governmental & Specialty RX, LLC.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for CITALOPRAM (CITALOPRAM)